Hepatocellular carcinoma (HCC) is one major cause of cancer-related death worldwide. But
now, the systematic therapy for the advanced stages of HCC is rather limited. Thus, the …

Liver cancer is among the top five death-causing malignancies. High mortality rate, poor
prognosis, and minimal drug options for hepatocellular carcinoma (HCC) patients led to the …

Hepatocellular carcinoma (HCC) is a malignant tumor with high mortality. This study aimed
to build a prognostic signature for HCC patients based on immune-related genes (IRGs) and …

Background: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related
death globally. The mechanisms underlying the development of HCC are mostly unknown …

Hepatocellular carcinoma (HCC) is a significant health problem worldwide with poor
prognosis. Drug repositioning represents a profitable strategy to accelerate drug discovery …

Background: Hepatocellular carcinoma (HCC) frequently recurs and has poor prognosis,
and thus it is essential to investigate the molecular mechanisms associated with HCC …

Hepatocellular carcinoma (HCC) is the fourth most common primary liver tumor and is an
important medical problem worldwide. However, the use of current therapies for HCC is no …

Hepatocellular carcinoma (HCC) is the most common malignant liver disease in the world.
However, the mechanistic relationships among various genes and signaling pathways are …

Hepatocellular carcinoma (HCC) is a major cause of cancer-related death worldwide. Up to
date, HCC pathogenesis has not been fully understood. The aim of the present study was to …

Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related
deaths worldwide. Patients suffering from HCC are usually diagnosed during an advanced …